Upgrade to SI Premium - Free Trial

Cerevel Therapeutics (CERE) PT Raised to $30 at Goldman Sachs

June 30, 2021 9:13 AM
Goldman Sachs analyst Graig Suvannavejh ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles